Publications
Securities Class Actions in the Life Sciences Sector
Spring 2025
Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2024.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 49 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2024.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
Knowledge Management Lawyer Zarine Alam also contributed to the 2024 annual report.
Contacts
西雅图
+1 415 439 1799西雅图
西雅图 98104
Capabilities
Suggested News & Insights
Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health InsightsThursday, March 12, 2026Generative AI and Privilege: Practical Lessons from Two Early Decisions and What Comes NextFebruary 27, 2026Sidley Represents Precision NeuroMed in Its Strategic Partnership With Brainlab SEFebruary 27, 2026TX AG’s Office Continues Aggressive Enforcement Against Healthcare Entities Operating in TexasFebruary 25, 2026New York LLC Transparency Act Took Effect January 1, 2026; U.S.-Formed LLCs Exempt from Reporting ObligationsFebruary 25, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory